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Mapping proteomic composition at distinct genomic loci and subnuclear 41	
landmarks in living cells has been a long-standing challenge. Here we report that 42	
dCas9-APEX2 Biotinylation at genomic Elements by Restricted Spatial Tagging (C-43	
BERST) allows the rapid, unbiased mapping of proteomes near defined genomic 44	
loci, as demonstrated for telomeres and centromeres. By combining the spatially 45	
restricted enzymatic tagging enabled by APEX2 with programmable DNA 46	
targeting by dCas9, C-BERST has successfully identified nearly 50% of known 47	
telomere-associated factors and many known centromere-associated factors.  We 48	
also identified and validated SLX4IP and RPA3 as telomeric factors, confirming C-49	
BERST’s utility as a discovery platform. C-BERST enables the rapid, high-50	
throughput identification of proteins associated with specific sequences, 51	
facilitating annotation of these factors and their roles in nuclear and chromosome 52	
biology.     53	
 54	
 55	
Three-dimensional organization of chromosomes is being defined at ever-increasing resolution 56	
through the use of Hi-C and related high-throughput methods1. Genome organization can also 57	
be analyzed in live cells by fluorescence imaging, especially via fluorescent protein (FP) fusions to 58	
nuclease-dead Streptococcus pyogenes Cas9 (dSpyCas9), which can be directed to nearly any genomic 59	
region via single-guide RNAs (sgRNAs)2. It has proven more difficult to map subnuclear 60	
proteomes onto 3-D genome landscapes in a comprehensive manner that avoids demanding 61	
fractionation protocols, specific DNA-associated protein fusions [e.g. in proximity-dependent 62	
biotin identification (BioID3)], or validated antibodies. dSpyCas9 has enabled a BioID-derived 63	
subnuclear proteomic technique called CasID4, in which biotin ligase (BirA*) fusion to dSpyCas9 64	
allows proteins associated with specific genomic regions to be biotinylated on neighboring, 65	
exposed lysine residues in live cells. Streptavidin affinity selection and liquid 66	
chromatography/tandem mass spectrometry (LC-MS/MS) is then used to identify the tagged 67	
proteins. However, this approach is relatively inefficient and usually involves long (18-24h) 68	
labeling times, limiting the time resolution of dynamic processes. Similar considerations apply to 69	
the recently reported CAPTURE approach for subnuclear proteomics5, in which dSpyCas9 itself 70	
is biotinylated by BirA* and used as an affinity handle. 71	
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Engineered ascorbate peroxidase (APEX2) has been used for an alternative live-cell 72	
biotinylation strategy called spatially restricted enzymatic tagging (SRET)6, 7. In this approach, 73	
APEX2 is fused to a localized protein of interest, and cells are then treated with biotin-phenol 74	
(BP) and H2O2, generating a localized (within a ~20nm radius) burst of diffusible but rapidly 75	
quenched biotin-phenoxyl radicals. These products react with electron-rich amino acid side 76	
chains (e.g. Tyr, Trp, His and Cys), leading to covalent biotinylation of proteins in the vicinity of 77	
the localized APEX2, thus allowing subsequent identification by streptavidin selection and LC-78	
MS/MS. Notably, this subcellular tagging method is extremely efficient (1 min H2O2 treatment), 79	
allowing temporal control over the labeling process. Based in part on the success of dSpyCas9-FP 80	
fusions in enabling subnuclear imaging in living cells, we reasoned that a dSpyCas9 derivative 81	
that emits radicals rather than photons could be used for subnuclear proteomic analyses in a 82	
manner that overcomes the unfavorable kinetics and high background of CasID. Here we use 83	
dSpyCas9-APEX2 fusions in the development of C-BERST (Fig. 1a) for genomic element-84	
specific profiling of subnuclear proteomes in live cells. 85	
 86	
Results 87	
 88	
C-BERST design and workflow 89	
To develop and validate this method, we sought genomic elements that are associated 90	
with a well-defined suite of known protein factors, and that can be bound with dSpyCas9 with 91	
high efficiency and specificity using an established sgRNA. For this purpose, we chose to target 92	
telomeres in human U2OS cells. As with ~10-15% of cancer cell types, U2OS cells rely on 93	
alternative lengthening of telomeres (ALT) pathways to maintain telomere length without 94	
telomerase activation8. Cohorts of proteins associated with telomeres in ALT+ cells are well-95	
characterized, and they map to key pathways such as homologous recombination (HR) and 96	
break-induced telomere synthesis9. Furthermore, an sgRNA (sgTelo) has already been established 97	
for efficient telomere association of dSpyCas910, 11.  98	
We transduced U2OS cells with a lentiviral vector expressing dSpyCas9 under the 99	
control of a tet-on CMV promoter and fused to five nuclear localization signals (NLSs), a ligand-100	
tunable degradation domain (DD)12, mCherry, and APEX2 (Fig. 1b). Maximal expression of 101	
this dSpyCas9-mCherry-APEX2 fusion protein requires not only doxycycline (dox) but also the 102	
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Shield1 ligand to inactivate the DD in a dose-dependent fashion13. This combination allows 103	
precise control over dSpyCas9-mCherry-APEX2 protein levels for optimal signal-to-noise levels. 104	
mCherry-positive cells [collected by fluorescence-activated cell sorting (FACS)] were then 105	
transduced with a separate lentiviral vector that included an sgRNA construct (driven by the U6 106	
promoter) as well as a blue fluorescent protein (BFP) construct that also expresses the TetR 107	
repressor (Fig. 1b). In one version of this construct the sgRNA cassette encodes sgTelo (for 108	
labeling telomeres), and in the other it encodes a non-specific sgRNA (sgNS) that is 109	
complementary to a bacteriophage-derived sequence that is absent from the human genome14. 110	
After 21h of dox and Shield1 induction, we again used fluorescence-activated sorting (FACS) to 111	
sort four distinct BFP/mCherry double-positive cell populations (P1-P4) that correlate with 112	
different expression levels of dSpyCas9-mCherry-APEX2 and BFP (as a surrogate for sgRNA 113	
and TetR) (Fig. 1c and Supplementary Fig. 1). We reasoned that our signal-to-noise ratio of 114	
telomeric vs. non-telomeric biotinylation would be maximized when sgTelo levels are saturating, 115	
and when dSpyCas9-mCherry-APEX2 levels are limiting (relative to potential genomic binding 116	
sites). Both conditions are expected to favor maximal partitioning of the sgRNA-programmed 117	
dSpyCas9-mCherry-APEX2 into the desired telomere-associated state, with as little unlocalized 118	
or mislocalized fusion protein as possible. Visual inspection by fluorescence microscopy 119	
(Supplementary Fig. 2) confirmed that the sgTelo P1 cell population (with higher BFP 120	
expression and lower mCherry expression, about 20% of the total sorted cells) exhibited the most 121	
robust mCherry-labelled telomeric foci (as determined by colocalization with anti-TERF2IP 122	
immunofluorescence) with the lowest amount of nucleolar or diffuse nucleoplasmic background10. 123	
We therefore used this population in our subsequent experiments.  124	
To assess the distribution of biotinylated proteins in the nucleus, we used avidin-125	
conjugated Oregon Green 488 (OG 488) to probe sgTelo and sgNS cells after BP and H2O2 126	
treatment. We found that biotinylated proteins were strongly enriched at telomeric foci in sgTelo 127	
cells, whereas labeling was diffuse in sgNS cells (Fig. 1d). Efficient labeling was BP- and H2O2- 128	
dependent. We also analyzed genome-wide dCas9-mCherry-APEX2 binding via anti-mCherry 129	
chromatin immunoprecipitation and sequencing (ChIP-seq). Nearly 60% of total trimmed reads 130	
from sgTelo cells contained at least one (TTAGGG)4 sequence (the minimal length of telomeric 131	
repeats with full complementarity to sgTelo). However, such (TTAGGG)4-containing reads 132	
comprised <0.5% of total trimmed reads from either sgNS or untransduced U2OS cells 133	
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(Supplementary Fig. 3). These experiments indicate that sgTelo-guided dCas9-mCherry-134	
APEX2 targets telomeres and enables restricted biotinylation of endogenous proteins near these 135	
chromosomal elements. 136	
 137	
Label-free profiling of telomere-associated proteomes using C-BERST 138	
For proteomic analysis, we induced APEX2-catalyzed biotinylation with BP and H2O2 in 139	
the sgTelo and sgNS P1-sorted cells (~6 x 107 cells for each guide), and also included an sgTelo 140	
control in which the H2O2 was omitted. APEX2-catalyzed biotinylation of nucleoplasmic 141	
proteins in the sgNS control sample serves as a reference, permitting an assessment of the 142	
telomere specificity of labeling in the sgTelo sample. Nuclei were isolated from treated cells (to 143	
reduce cytoplasmic background), and nuclear proteins were then extracted. Recovered proteins 144	
(50 µg) were subjected to western blot analysis using streptavidin-conjugated horseradish 145	
peroxidase (streptavidin-HRP) (Fig. 2a), as well as total protein visualization by Coomassie 146	
staining (Fig. 2b). Samples were also probed with anti-mCherry antibodies (to detect dSpyCas9-147	
mCherry-APEX2) and HDAC1 (as a loading control) (Fig. 2a, bottom). Biotinylated proteins 148	
were readily detected in both sgTelo and sgNS samples, but were largely absent in the -H2O2 149	
control (Fig. 2a). In the sgNS sample, anti-mCherry and streptavidin-HRP signals were less 150	
intense in comparison with the sgTelo sample, indicating that dSpyCas9-mCherry-APEX2 151	
accumulation and activity are lower in the former. Biotinylated proteins were then isolated using 152	
streptavidin beads and analyzed by SDS-PAGE and silver staining (Fig. 2c). Aside from the 153	
~75kDa endogenously biotinylated proteins routinely detected in SRET-labeled samples6, 7, only 154	
background levels of proteins were detected in the no-H2O2 control sample, indicating successful 155	
purification. All three samples were subjected to in-gel trypsin digestion followed by LC-MS/MS 156	
to identify the biotin-labeled proteins. These analyses were done with two biological replicates 157	
prepared on different days. 158	
The two sgTelo replicates yielded at least three peptides from 930 and 851 proteins, >85% 159	
of which (792) were detected in both (Supplementary Table 1). For these 792 proteins, we 160	
used intensity-based absolute quantification (iBAQ) values [a label-free quantification (LFQ) 161	
proteomic approach] to determine the degree of enrichment in the sgTelo sample relative to the 162	
sgNS sample. Some of these 792 proteins (104 in the first replicate, and 340 in the second) 163	
yielded no spectra whatsoever in the corresponding sgNS sample, consistent with sgTelo 164	
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specificity. In those cases, to avoid infinitely large sgTelo/sgNS enrichment scores, we assigned 165	
those proteins the smallest non-zero iBAQ value from the proteins positively identified in that 166	
sgNS dataset. The sgTelo/sgNS iBAQ ratios were then analyzed by moderated t-test, yielding 167	
143 proteins whose enrichment in sgTelo was statistically significant [Benjamini-Hochberg (BH)-168	
adjusted p < 0.05] [Fig. 2d (red and blue dots) and Supplementary Table 1]. Strikingly, the 169	
six subunits of the shelterin complex (a telomere-binding complex that protects ends from 170	
chromosome fusion15) were among the seven most significantly enriched proteins (Fig. 2d and 171	
Supplementary Table 1). Another highly enriched protein was Apollo, a 5’à3’ exonuclease 172	
that interacts with the shelterin component TRF2 and functions in the ALT pathway16. Overall, 173	
among the 143 most significantly sgTelo-enriched proteins (Supplementary Table 1), 30 have 174	
been reported previously to be associated with telomeres or linked to telomere function 175	
(Supplementary Table 2). These results indicate that validated telomeric proteins can be 176	
identified rapidly and efficiently by C-BERST. 177	
 178	
Ratiometric proteomics enhances the sensitivity and specificity of C-BERST 179	
To further improve our assessments of differential C-BERST biotinylation with specific vs. 180	
non-specific sgRNAs, we used a more quantitative proteomic approach enabled by stable isotope 181	
labeling with amino acids in cell culture (SILAC) to analyze telomere-associated proteomes. 182	
sgTelo/dCas9-mCherry-APEX2 cells were cultured in heavy-isotope medium, sgNS/dCas9-183	
mCherry-APEX2 cells were cultured in medium-isotope medium, and untransduced U2OS cells 184	
were cultured in light-isotope medium, each for at least 5 passages to allow sufficient 185	
incorporation of isotope-labeled arginine and lysine (Supplementary Fig. 4a). We then 186	
induced dCas9-mCherry-APEX2 expression by dox and Shield1 for 21 hours, with comparable 187	
accumulation with either sgTelo or sgNS (Supplementary Fig. 4b). Biotinylation and cell lysis 188	
were then performed as described above, except that equal amounts (~1 mg, measured by Pierce 189	
BCA Protein Assay Kit) of protein lysates from heavy, medium, and light samples (H:M:L = 190	
1:1:1) were mixed before streptavidin affinity purification for three-state SILAC6. 913 proteins 191	
were identified in both the heavy and medium samples, and 885 of these were also detectable in 192	
the light (no-APEX2 background) sample. Using significance (BH-adjusted p < 0.01) and 193	
enrichment ([log2 fold change (FC) ≥ 2.5]) cut-offs that were even more stringent than those 194	
used for the label-free analysis (Fig. 2d), we identified 55 proteins that are strongly enriched in 195	
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the sgTelo sample relative to sgNS (H/M) (Fig. 3 and Supplementary Table 3). Among these 196	
55 proteomic hits, 34 are known telomere-associated factors, including all six shelterin 197	
components as well as subunits from 5 other complexes that are known to contribute to ALT-198	
associated pathways or processes (Supplementary Fig. 5). All but one of the 55 H/M-enriched 199	
proteins (BARD1) were also strongly enriched (log2 FC ≥ 1) in H/L ratio, indicating that 200	
background detection in the absence of dCas9-mCherry-APEX2 biotinylation was minimal. 201	
Gene ontology (GO) analysis of the 55 H/M-enriched C-BERST hits reveals strong functional 202	
associations with terms such as telomere maintenance, DNA replication, DNA repair, and 203	
homologous recombination, all of which are important for ALT pathways8 (Fig. 4a).  204	
Telomere-associated proteomes from ALT+ cell lines have been defined previously by 205	
TRF1-BirA* BioID in U2OS cells17, and by biochemical purification [proteomics of isolated 206	
chromatin segments (PICh)] from WI38-VA13 cells18. Protein identifications from these analyses, 207	
as well as from our C-BERST SILAC dataset, were examined for overlap as depicted in the 208	
Venn diagram shown in Fig. 4b. Of the 55 proteins identified by C-BERST, 32 (~58%) were 209	
also detected by one or both of the other methods [23 by BioID (p = 7.29 x 10-32), 27 by PICh (p 210	
= 2.04 x 10-50), and 18 by both]. The remaining 23 proteins that were uniquely detected by C-211	
BERST include seven known telomeric/ALT factors (ATR, CTC1, FANCA, FANCD2, 212	
FANCM, SMC5, and WRN). Of the 18 proteins detected by all three approaches, 17 are known 213	
telomere-related factors. The remaining consensus hit [SLX4-interacting protein (SLX4IP)] was 214	
not previously validated as telomeric in the BioID and PICh studies; nonetheless its identification 215	
by all three proteomic approaches strongly suggests that it has a previously unappreciated role in 216	
telomere function or maintenance (Fig. 4c). Such a role could be related to that of its binding 217	
partner SLX4 in the resolution of telomere recombination intermediates19.  218	
To validate the ability of C-BERST to identify novel or provisional telomeric or ALT-219	
related proteins, we used independent methods to assess telomere colocalization of SLX4IP, as 220	
well as a factor (RPA3) that was detected by C-BERST [ranked 44th (log2FC) among the 55 221	
enriched proteins] but missed by BioID and PICh. We transiently transfected U2OS cells with 222	
turboGFP-tagged SLX4IP, and then analyzed cells for its appearance in endogenous TRF2-223	
colocalizing foci, as indicated by anti-TRF2 immunofluorescence (Fig 4d). SLX4IP-GFP signal 224	
was evident in some but not all TRF2 foci, confirming that it localizes to a subset of telomeres. 225	
This conclusion was further corroborated by immunofluorescence detection of endogenous 226	
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SLX4IP, which again revealed TRF2 colocalization (Supplementary Fig. 6). We also 227	
transfected U2OS cells with RPA3-GFP, and again we detected it in a subset of TRF2 foci (Fig 228	
4d). Due to high background staining by the commercial anti-RPA3 antibody, we were unable 229	
to analyze TRF2 colocalization by endogenous RPA3, but western analyses confirmed that the 230	
RPA3-GFP fusion protein (like the anti-SLX4IP fusion protein) was expressed at or below the 231	
levels of the endogenous protein under the conditions used for fluorescence microscopy 232	
(Supplementary Fig. 7). RPA3 is a subunit of the RPA complex, which has known functions 233	
in ALT pathways20; in addition, other RPA subunits (RPA1 and RPA2) were enriched in PICh18 234	
as well as C-BERST. Therefore the partial telomeric localization of RPA3 is not altogether 235	
surprising, despite the fact that it was not detected by either PICh or BioID. The incomplete 236	
overlap for SLX4IP and RPA3 with the telomeric marker is consistent with previously defined 237	
non-telomeric functions for both SLX4IP21 and RPA322, and indicate that C-BERST is 238	
sufficiently sensitive and specific to detect telomere-associated factors even with proteins that are 239	
only partially (or perhaps transiently) telomeric. 240	
 241	
C-BERST subnuclear proteomics at centromeres 242	
To extend our subnuclear proteomic approach to other genomic elements, we targeted 243	
dCas9-mCherry-APEX2 to centromeric alpha-satellite arrays in U2OS cells, and then used C-244	
BERST to profile the protein components of alphoid chromatin (Figure 5a) using a similar 245	
pipeline as that described above for telomeres. The human alpha satellite proteome from K562 246	
cells has been analyzed previously using the PICh-related protocol known as HyCCAPP 247	
(hybridization capture of chromatin-associated proteins for proteomics), again providing a basis 248	
for comparison. Via live-cell imaging (Figure 5b) and western blotting (Supplementary Fig. 249	
8), we have confirmed dCas9-mCherry-APEX2 inducible expression, specific centromere 250	
targeting23, and biotinylation. We used SILAC proteomic analysis (heavy, sgAlpha; medium, 251	
sgNS; light, untransduced U2OS cells lacking dCas9-mCherry-APEX2) and identified 1268 252	
proteins (Supplementary Table 4) from each of two biological replicates (based upon 253	
detection in at least two of three technical replicates of each biological replicate). Among these 254	
1268 proteins, 460 were enriched to a statistically significant extent (log2FC ≥ 2.5 and p < 0.01) 255	
in the sgAlpha vs. sgNS samples (H/M). We have identified four highly enriched subunits of the 256	
CENP-A nucleosome-associated complex24 (CENP-C, -M, -N, and –T), and one subunit (CENP-257	
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P) of the CENP-A distal complex24. We also identified nearly all CENP-A loading factors25, 258	
including HJURP, Mis18a, Mis18b, and MIS18BP1, among the enriched proteins. Many other 259	
known centromere-associated proteins were also identified as enriched in sgAlpha including 260	
CENP-B, -F, -I, and -L, as well as KNL1. Additionally, we identified three subunits of the 261	
chromosome passenger complex [INCENP, CDCA8, and Aurora kinase B (AURKB)], which 262	
has been suggested to localize to the centromere during mitosis26. We also found Fanconi anemia 263	
pathway proteins such as FANCM, which has been implicated in promoting centromere 264	
stability27. There are 31 overlapping enriched proteins (p = 3.84 x 10-38) between C-BERST and 265	
HyCCAPP, despite the use of different cancer cell lines in the respective studies 266	
(Supplementary Fig. 9a). C-BERST uniquely captured multiple known centromeric factors 267	
including CENP-F and ATR, which were recently reported to localize to centromeres and 268	
engage RPA-coated R loops28. GO analysis of the 460 C-BERST centromeric hits reveals strong 269	
functional associations with terms such as DNA repair, DNA replication, sister chromatid 270	
cohesion, double-strand break repair by homologous recombination, mitotic nuclear division, 271	
and cell division, all of which are related to centromere maintenance or function8 272	
(Supplementary Fig. 9b).  273	
Our generation of both telomeric and centromeric C-BERST datasets affords the 274	
opportunity to compare SILAC-based protein enrichment at these two chromosomal landmarks. 275	
Of the 55 and 460 C-BERST enriched proteins at ALT+ telomeres and centromeres, 276	
respectively, 36 were identified in both (p = 1.31 x 10-57) (Supplementary Fig. 10). Significant 277	
GO terms for these 36 overlapping proteins include DNA replication, regulation of signal 278	
transduction by p53 class mediator, strand displacement, double strand break repair via 279	
homologous recombination, and DNA repair, each of which would be expected for both 280	
categories of chromosomal elements. Significantly, all CENP factors were found among the 424 281	
non-overlapping proteins from the sgAlpha centromeric dataset. Conversely, the 19 telomere-282	
specific hits (enriched only with sgTelo and not sgAlpha) include five of the six shelterin subunits 283	
(TRF1, TERF2IP, TIN2, POT1, TPP1); intriguingly, the sixth (TRF2) has previously been 284	
reported to associate with CENP-F29. These results provide strong evidence that C-BERST 285	
successfully measures subnuclear protein enrichment at distinct chromosomal elements.   286	
 287	
 288	
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Discussion 289	
 We demonstrate that C-BERST successfully maps subnuclear proteomes associated with 290	
genomic landmarks. Using the extensively investigated ALT telomeric proteome as an initial 291	
benchmark for our ratiometric implementation of C-BERST, we recover approximately 44% of 292	
known ALT-associated proteins (34 of 78, Supplementary Tables 2 and 3) as strongly 293	
enriched at telomeres, in addition to factors involved in all reported biological processes that 294	
contribute to ALT. Combining C-BERST with SILAC made it possible to set very high 295	
enrichment cut-offs (BH-adjusted p < 0.01, log2FC ≥ 2.5]) while still retaining excellent 296	
representation of the known telomeric or centromeric factors that we employed as benchmarks; 297	
lower thresholds can be set where appropriate to cast a wider net for previously unknown factors. 298	
We used fluorescence microscopy to validate a strongly enriched C-BERST hit (SLX4IP) whose 299	
telomeric localization had not been previously confirmed, and another (RPA3) that was missed 300	
by previous subnuclear proteomic approaches such as BioID17 and PICh18. Importantly, we 301	
extended C-BERST to a second category of genomic elements (alpha satellite centromeric 302	
sequences) and identified a distinct set of enriched factors that included many known centromeric 303	
factors, and that largely excluded known telomere-specific factors (including those enriched by 304	
telomeric C-BERST). These results provide strong indications that C-BERST can successfully 305	
profile subnuclear proteomes based upon proximity to specific classes of genomic sequence. C-306	
BERST is also compatible with other ratiometric approaches such as tandem mass tagging 307	
(TMT)30. Although ratiometric approaches increase the sensitivity and quantitative rigor of C-308	
BERST enrichment, more economical label-free quantitation can also be used successfully with 309	
C-BERST, as we showed for telomeres. 310	
By combining the flexibility of RNA-guided dSpyCas9 genome binding with the 311	
efficiency and rapid kinetics of APEX2-catalyzed biotinylation, C-BERST promises to extend the 312	
unbiased definition of subnuclear proteomes to many other genomic elements, and to a range of 313	
dynamic processes (e.g. cellular differentiation, responses to extracellular stimuli, and cell cycle 314	
progression) that occur too rapidly to analyze via the longer labeling procedures often necessary 315	
for CasID4, CAPTURE5, and related BirA*-based approaches. Furthermore, we found 40-60 316	
million cells to provide a sufficient sample size for telomeric and centromeric C-BERST, in 317	
contrast to the >109 cells reported as inputs for CasID, CAPTURE, and PICh4, 5, 18. The ability 318	
to apply C-BERST to smaller populations of cells provides an obvious cost savings, and may also 319	
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be important when available cell numbers are limiting due to their proliferation properties or 320	
challenges in their manipulation. Finally, C-BERST and BirA*-based methods favor 321	
biotinylation of distinct sets of proteins by virtue of their different labeling specificities (lysines for 322	
BirA*, and predominantly tyrosines for C-BERST); using these approaches in tandem would 323	
likely diminish the number of false negatives resulting from inefficient labeling due to differences 324	
in the surface-accessible amino acid distribution or the suitability of certain peptides for MS 325	
analysis.  326	
Importantly, C-BERST promises to augment and extend Hi-C and related methods by 327	
linking conformationally important cis-elements with the factors that associate with them. Guide 328	
RNA multiplexing should enable the extension of C-BERST subnuclear proteomics to single-329	
copy, non-repetitive loci. In the meantime, many types of repetitive elements within the genome, 330	
like telomeres and centromeres, play critically important roles in chromosome maintenance and 331	
function in ways that depend upon their associated proteins; C-BERST provides an unbiased 332	
method for sampling subnuclear, locus-specific proteomics at these elements to define protein 333	
factors that are critical to their functions.            334	
 335	
METHODS 336	
Methods, data files, and any associated references are available in the online version of the paper.  337	
Note: Any Supplemental and Source Data files are available in the online version of the paper. 338	
 339	
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ONLINE METHODS  430	
 431	
Construction of C-BERST plasmids. The Shield1- and doxycycline-inducible dSpyCas9-432	
mCherry-APEX2 construct was made by subcloning Flag-APEX2 from Flag-APEX2-NES 433	
(Addgene 49386) into DD-dSpyCas9-mCherry13 using the pHAGE backbone. Two additional 434	
NLSs (SV40 and nucleoplasmin NLS) were inserted at each terminus to improve nuclear 435	
localization. The sequence of the final plasmid is provided in the Supplementary Note. The 436	
sgTelo-encoding construct was created by replacing the C3-guide RNA sequence (pCMV_C3-437	
sgRNA_2XBroccoli/pPGK_TetR_P2A_BFP) with sgTelo sequences (using a plasmid provided 438	
by Hanhui Ma and Thoru Pederson). Non-specific sgRNA (sgNS)14 and sgAlpha were 439	
constructed similarly. SLX4IP-turboGFP plasmid was obtained from OriGene (catalog number: 440	
RG220896). RPA3-turboGFP was made by replacing the SLX4IP coding sequence with the 441	
human RPA3 coding sequence.  442	
 443	
 444	
Cell culture and cell line construction. Human U2OS cells obtained from Thoru 445	
Pederson’s lab (originally obtained from ATCC) were cultured in Dulbecco-modified Eagle’s  446	
Minimum Essential Medium (DMEM; Life Technologies) supplemented with 10% (vol/vol) FBS 447	
(Sigma). Lentiviral transduction was as described13. Six-fold higher titers of sgRNA-encoding 448	
lentiviruses were used for transduction relative to dSpyCas9-APEX2 lentivirus. Stably transduced 449	
cells were grown under the same conditions as the parental U2OS cells. 450	
 451	
 452	
Flow cytometry. One day before performing FACS, dox (Sigma; 2 µg/ml) and Shield1 453	
(Clontech; 250 nM) were added to the media. ~2 x 106 cells expressing dSpyCas9-mCherry-454	
APEX2 and BFP sgRNA were selected by FACSAria cell sorter or analyzed with MacsQuant® 455	
VYB. Both instruments are equipped with 405- and 561-nm excitation lasers, and the emission 456	
signals were detected by using filters at 450/50 nm (wavelength/bandwidth) for BFP, and 457	
610/20 nm (FACSAria) or 615/20nm (MacsQuant) for mCherry. Bulk population and single 458	
cells (Supplementary Fig. 1b) were sorted into plates containing 1% GlutaMAX, 20% FBS, 459	
and 1% penicillin/streptomycin in DMEM medium.   460	
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 461	
Fluorescence microscopy. U2OS cells expressing sgRNA were seeded onto 170 μm, 35 × 10 462	
mm glass-bottom dishes (Eppendorf) supplemented with dox and Shield1 21 hours before 463	
imaging. Live cells were imaged with a Leica DMi8 microscope equipped with a Hamamatsu 464	
camera (C11440-22CU), a 63x oil objective lens, and Microsystems software (LASX). Further 465	
imaging processing was done with MetaMorph (Molecular Devices). Image contrast was set to 466	
ease visualization of cell, foci and nucleoplasmic background. 467	
 468	
Immunofluorescence microscopy. Cells for immunofluorescence microscopy were grown 469	
on glass coverslips. The transfected cells or normal cells were fixed for 15 minutes in 2% 470	
paraformaldehyde in PHEM [0.05 M PIPES/0.05 M HEPES (pH 7.4), 0.01 M EGTA, 0.01 M 471	
MgCl2], followed by a 2-min. extraction with 0.1% Triton X-100 in PHEM. After PBS washes, 472	
the cells were blocked by 1% BSA/1X TBST at 4°C overnight. Cells were first incubated with 473	
primary antibodies for two hours at room temperature and washed three times with blocking 474	
solution (10 minutes/wash). Cells were then incubated with secondary antibodies for one hour at 475	
room temperature, followed by another three blocking solution washes and two PBS washes31. 476	
Cells were mounted with ProLong antifade and visualized by fluorescence microscopy as 477	
described above. Neutravidin conjugated with OG488 experiment was described previously6. 478	
 479	
C-BERST biotinylation protocol. Six 15cm plates of U2OS cells (~6 x 107) expressing 480	
specific (sgTelo or sgAlpha) or nonspecific (sgNS) sgRNAs were used in this assay. Dox (2 µg/ml) 481	
and Shield1 (250 nM) were added 21 hours before biotinylation. Cells were then incubated with 482	
500 µM biotin-phenol (BP) (Adipogen) for 30 minutes at 37°C. 1 mM H2O2 was then added to 483	
initiate of biotinylation for 1 minute on a horizontal shaker at room temperature. Six 15cm plates 484	
of sgTelo- or sgAlpha-expressing cells were treated in parallel, but without H2O2 addition, as a 485	
negative control. Quencher solution (5 mM trolox, 10 mM sodium ascorbate, and 10 mM 486	
sodium azide) was added to stop the reaction, and cells were washed five times (three quencher 487	
washes and two DPBS washes) to continue the quench and to remove excess BP.  488	
 489	
Enrichment of biotinylated proteins. Cells were scraped off the plates and used for the 490	
preparation of isolated nuclei32. Nuclei were washed with DPBS before lysis. RIPA lysis buffer 491	
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[50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.125% SDS, 0.125% sodium deoxycholate and 1% 492	
Triton X-100 in Millipore water) with 1x freshly supplemented Halt Protease Inhibitor were used 493	
to lyse the cells for 10 minutes on ice. Cell lysates in 1.5 ml Eppendorf tubes were sonicated for 494	
15 minutes with a Diagenode Bioruptor with 30s on/off cycles at high intensity. Cell lysates were 495	
clarified by centrifugation at 13,000 rpm for 10 minutes. Clarified protein samples (~3.5 mg) 496	
were subjected to 400 µl Dynabeads MyOne Streptavidin T1 affinity purification overnight at 497	
4°C. Each bead sample was washed with a series of buffers to remove non-specifically bound 498	
proteins: twice with RIPA lysis buffer, once with 1 M KCl, once with 0.1 M Na2CO3, once with 499	
2 M urea in 10mM Tris-HCl, pH 8.0, and twice with RIPA lysis buffer. Proteins were eluted in 500	
70 µl 3x protein loading buffer supplemented with 2 mM biotin and 20 mM DTT with heating 501	
for 10min at 95˚C6. 50 µl eluents were loaded and run on a 4-12% SDS-PAGE gel (Bio-Rad) and 502	
run approximately 1cm off the loading well for in-gel digestion and LC-MS/MS analysis. The 503	
gel-fractionated sample used for LC-MS/MS (see below) corresponded to proteins from ~4 x 107 504	
cells.     505	
 506	
Western blotting. Protein concentrations of the cell lysates were determined by BCA assay 507	
(Thermo). 50 ug of each sample was mixed with protein loading buffer, boiled, and separated in 508	
SDS-PAGE gels. Proteins were transferred to PVDF membrane (Millipore), and blotted with 509	
Streptavidin-HRP (Thermo), or with anti-mCherry (Abcam) or anti-HDAC1 (Bethyl) antibodies. 510	
Additional details of the anti-SLX4IP and anti-RPA3 western analyses are described in the figure 511	
legends.  512	
 513	
mCherry affinity purification of dSpyCas9-mCherry-APEX2 captured DNA and 514	
sequencing. 1 × 107 U2OS cells stably expressing dCas9-mCherry-APEX2 transduced with 515	
sequence-targeting or non-specific sgRNAs were washed with PBS, fixed with 1% formaldehyde 516	
for 10 min and quenched with 0.125 M glycine for 5 min. Cells were harvested using a plate 517	
scraper and lysed in RIPA cell lysis buffer [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.125% 518	
SDS, 0.125% sodium deoxycholate and 1% Triton X-100 in Millipore water] with 1x freshly 519	
supplemented Halt Protease Inhibitor for 10 minutes on ice. Cell lysates were centrifuged at 520	
2,300 x g for 5 min at 4°C to isolate nuclei. Nuclei were suspended in 500 μl of RIPA nuclear 521	
lysis buffer [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% SDS, 0.125% sodium deoxycholate 522	
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and 1% Triton X-100 in Millipore water] with 1x freshly supplemented Halt Protease Inhibitor 523	
and subjected to sonication to shear chromatin fragments to an average size of 200-500 bp on a 524	
Diagenode Bioruptor with 30s on/off cycles at high intensity for 15 minutes. Fragmented 525	
chromatin was centrifuged at 16,100 x g for 10 min at 4°C. 450 μl of supernatant was transferred 526	
to a new microcentrifuge tube. 4 μg anti-mCherry antibody (Thermo PA5-34974) was added to 527	
each sample and incubated at 4°C for 3h. 50μl of blocked Protein G Dynabeads (Thermo 528	
10003D) was added to each sample and rotated at 4°C overnight. After overnight incubation, 529	
Dynabeads were washed seven times as described above for selection of biotinylated proteins. 530	
Chromatin was eluted from Dynabeads in 200μl elution buffer [50 mM Tris-HCl (pH 8.0), 10 531	
mM EDTA, 1% SDS] and transferred to a new microcentrifuge tube. Eluted chromatin was 532	
treated with 1 μl RNase A and incubated overnight at 65°C to reverse crosslinks. 7.5 μl of 20 533	
mg/ml proteinase K was added to each sample followed by incubation for 2h at 50°C. ChIP 534	
DNA was then incubated with 1ml Buffer PB (QIAGEN) and 10 μl of 3M sodium acetate pH 5.2 535	
at 37°C for 30 minutes. DNA was purified using QIAGEN quickspin column. 536	
15 ng of ChIP DNA was processed for library preparation using the NEBNext ChIP-seq Library 537	
Prep Kit (New England Biolabs) according to the manufacturer’s protocol.  538	
15 ng of ChIP DNA was end-repaired using NEBNext End Repair module (NEB Cat. E6050) 539	
and purified with 1.8x AMPure XP beads (Beckman-Coulter Cat. A63880). End-repaired DNA 540	
was processed in a dA-tailing reaction using NEBNext dA-Tailing module (NEB Cat. E6053) and 541	
purified with 1.8x AMPure XP beads. Adaptor oligos 1 (5′-pGAT CGG AAG AGC ACA CGT 542	
CT-3′) and 2 (5′-ACA CTC TTT CCC TAC ACG ACG CTC TTC CGA TCT-3′) used in Y-543	
shaped adapter mix were ligated to dA-tailed DNA according to ref. 33 and purified with 1.5x 544	
AMPure XP beads. Ligated DNA was incubated in a thermal cycler (98°C for 40s, 65°C for 30s, 545	
and 72°C 30s) with Illumina barcode primers 2-1 (5′-CAA GCA GAA GAC GGC ATA CGA 546	
GAT CGT GATGTG ACT GGA GTT CAG ACG TGT GCT CTT CCG ATC T-3′), 2-2 (5′-547	
CAA GCA GAA GAC GGC ATA CGA GAT ACA TCGGTG ACT GGA GTT CAG ACG 548	
TGT GCT CTT CCG ATC T-3′), 2-3 (5′-CAA GCA GAA GAC GGC ATA CGA GAT GCC 549	
TAAGTG ACT GGA GTT CAG ACG TGT GCT CTT CCG ATC T-3′) and NEB Q5 550	
Polymerase Master Mix. Primer 1 (5′-AAT GAT ACG GCG ACC ACC GAG ATC TAC ACT 551	
CTT TCC CTA CAC GAC GCT CTT CCG ATC T-3′) was added to mix for 10 cycles (98°C 552	
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for 10s, 65°C for 30s, 72°C for 30s), followed by incubation at 72°C for 3 minutes. PCR-553	
enriched DNA was purified with 1x AMPure XP beads. 554	
Raw Illumina sequencing reads of 150 nucleotide length were processed as fastq files in R. Reads 555	
were trimmed using the Bioconductor ShortRead R package at positions which contained 2 556	
nucleotides in a 5-nucleotide bin with a quality encoding less than phred score = 20. Reads with 557	
at least one (TTAGGG)4 or (CCCTAA)4 segment constituted a “hit”, and were counted using 558	
the Bioconductor Biostrings R package. (number of hits / total trimmed reads) was calculated to 559	
assess the specificity of Cas9-mCherry-APEX2 for each sample.  560	
 561	
SILAC labeling. On day 0, early-passage, sorted, stably transduced sgTelo or sgAlpha U2OS 562	
cells were grown in heavy SILAC media, which contained L-arginine-13C6, 15N4 (Arg10) and L-563	
lysine-13C6, 15N2 (Lys8) (Sigma). Stable sgNS cells were grown in medium SILAC media, which 564	
contained L-arginine-13C6 (Arg6) and L-lysine-4,4,5,5-d4 (Lys4) (Sigma). Untransduced U2OS 565	
cells were grown in light SILAC media, which contained L-arginine (Arg0) and L-lysine (Lys0) 566	
(Sigma). Cells were grown for more than 10 days (>5 passages) to allow for sufficient 567	
incorporation of the isotopes. On day 11, dox and Shield1 were added to each isotope culture (4 568	
plates for each cell line) 21h before BP and H2O2 treatment. The biotinylation, nuclei isolation, 569	
and cell lysis followed the procedure described above. Before streptavidin affinity purification, 570	
equal amount of proteins measured by PierceTM BCA Protein Assay Kit (~1mg from each 571	
isotope sample) were mixed in a 1:1:1 ratio (H:M:L). Streptavidin affinity purification and sample 572	
wash were described above. Proteins were eluted in 50 µl 3x protein loading buffer supplemented 573	
with 2 mM biotin and 20 mM DTT with heating for 10min at 65˚C. 50 µl eluents were loaded 574	
and run approximately to the center of the lane on a 4-12% SDS-PAGE gel (Bio-Rad). The 575	
coomassie-stained protein bands were excised and cut to five slices for in-gel digestion and LC-576	
MS/MS analysis.     577	
 578	
LC-MS/MS and proteomic analyses for LFQ. Unresolved protein bands from SDS-579	
PAGE were cut into 1x1 mm pieces and placed in 1.5ml Eppendorf tubes with 1ml of water. 580	
After 30 min, water was removed and replaced with 70 µl of 250 mM ammonium bicarbonate. 581	
Proteins were then reduced by the addition of 20 µl of 45 mM 1,4-dithiothreitol, incubated at 582	
50˚C for 30 min, cooled to room temperature, alkylated with 20 µl of 100 mM iodoacetamide for 583	
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30 min, and washed twice with 1 ml water. The water was removed and replaced with 1 ml of 50 584	
mM ammonium bicarbonate: acetonitrile (1:1) and incubated at room temperature for 1 hr. The 585	
solvent was then replaced with 200 µl acetonitrile, removed, and the pieces dried in a Speed Vac. 586	
Gel pieces were then rehydrated in 75 µl of 4 ng/µl sequencing-grade trypsin (Promega) in 0.01% 587	
ProteaseMAX Surfactant (Promega) in 50 mM ammonium bicarbonate and incubated at 37˚C 588	
for 21 hr. The supernatant was then removed to a 1.5 ml Eppendorf tube, the gel pieces further 589	
dehydrated with 100 µl of acetonitrile: 1% (v/v) formic acid (4:1), and the combined supernatants 590	
dried on a Speed Vac. Peptides were then reconstituted in 25 µl of 5% acetonitrile containing 0.1% 591	
(v/v) trifluoroacetic acid for LC-MS/MS.  592	
Samples were analyzed on a NanoAcquity UPLC (Waters Corporation) coupled to a Q Exactive 593	
(Thermo Fisher Scientific) hybrid mass spectrometer. In brief, 1.0 µl aliquots were loaded at 4 594	
µl/min onto a custom-packed fused silica precolumn (100 µm ID) with Kasil frit containing 2 cm 595	
Magic C18AQ (5µm, 100Å) particles (Bruker Corporation). Peptides were then separated on a 596	
75µm ID fused silica analytical column containing 25 cm Magic C18AQ (3µm, 100Å) particles 597	
(Bruker) packed in-house into a gravity-pulled tip. Peptides were eluted at 300 nl/min with a 598	
linear gradient from 95% solvent A (0.1% (v/v) formic acid in water) to 35% solvent B (0.1% 599	
(v/v) formic acid in acetonitrile) in 60 min. Data was acquired by data-dependent acquisition 600	
according to a published method34. Briefly, MS scans were acquired from m/z 300-1750 at a 601	
resolution of 70,000 (m/z 200) and followed by ten tandem mass spectrometry scans using HCD 602	
fragmentation using an isolation width of 1.6 Da, a collision energy of 27%, and a resolution of 603	
17,500 (m/z 200). Raw data files were processed with Proteome Discoverer (Thermo, version 604	
2.1.1.21) and searched with Mascot (Matrix Science, version 2.6) against the SwissProt Homo 605	
sapiens database. Search parameters used tryptic specificity considering up to 2 missed cleavages, 606	
a parent mass tolerance of 10 ppm, and a fragment mass tolerance of 0.05 Da. Fixed 607	
modification of carbamidomethyl cysteine was considered as were variable modifications of N-608	
terminal acetylation, N-terminal conversion of Gln to pyroGlu, oxidation of methionine, and 609	
biotin-phenol conjugation of tyrosine. Results were loaded into Scaffold (Proteome Software Inc., 610	
version 4.8.4) for peptide and protein validation and quantitation using the Peptide Prophet and 611	
Protein Prophet algorithms35, 36. The threshold for peptides was set to 80% (1.1% FDR) and 90% 612	
for proteins (3-peptide minimum). Contaminants such as human keratin were included in all 613	
statistical analyses and removed from the figures.  614	
.CC-BY 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/171819doi: bioRxiv preprint first posted online Aug. 2, 2017; 
 22 
 615	
LC-MS/MS and proteomic analyses for SILAC. A fully resolved SDS-PAGE was cut into 616	
5 fractions and each fraction was processed separately as described. Gel bands were cut into 1x1 617	
mm pieces and placed in 1.5 mL eppendorf tubes with 1mL of water for 30 min. The water was 618	
removed and 200µl of 250 mM ammonium bicarbonate was added. For reduction, 20 µl of a 45 619	
mM solution of 1,4-dithiothreitol (DTT) was added and the samples were incubated at 50˚C for 620	
30 min. The samples were cooled to room temperature and then, for alkylation, 20 µl of a 100 621	
mM iodoacetamide solution was added and allowed to react for 30 min. The gel slices were 622	
washed twice with 1 mL water. The water was removed and 1mL of 50:50 (50 mM ammonium  623	
bicarbonate:acetonitrile) was placed in each tube and samples were incubated at room 624	
temperature for 1h. The solution was then removed and 200 µl of acetonitrile was added to each 625	
tube, at which point the gels slices turned opaque white.  The acetonitrile was removed and gel 626	
slices were further dried in a Speed Vac (Savant Instruments, Inc.). Gel slices were rehydrated in 627	
100 µl of 4ng/µl of sequencing-grade trypsin (Sigma) in 0.01% ProteaseMAX Surfactant 628	
(Promega):50 mM ammonium bicarbonate. Additional bicarbonate buffer was added to ensure 629	
complete submersion of the gel slices.  Samples were incubated at 37˚C for 18 hrs. The 630	
supernatant of each sample was then removed and placed in a separate 1.5 mL eppendorf tube.  631	
Gel slices were further extracted with 200 µl of 80:20 (acetonitrile:1% formic acid).  The extracts 632	
were combined with the supernatants of each sample. The samples were then completely dried 633	
down in a Speed Vac.   634	
Tryptic peptide digests were reconstituted in 25 µL 5% acetonitrile containing 0.1% (v/v) 635	
trifluoroacetic acid and separated on a NanoAcquity (Waters) UPLC. In brief, a 3.0 µL injection 636	
was loaded in 5% acetonitrile containing 0.1% formic acid at 4.0 µL/min for 4.0 min onto a 100 637	
µm I.D. fused-silica pre-column packed with 2 cm of 5 µm (200Å) Magic C18AQ (Bruker-638	
Michrom) and eluted using a gradient at 300 nL/min onto a 75 µm I.D. analytical column 639	
packed with 25 cm of 3 µm (100Å) Magic C18AQ particles to a gravity-pulled tip. The solvents 640	
were A, water (0.1% formic acid); and B, acetonitrile (0.1% formic acid). A linear gradient was 641	
developed from 5% solvent A to 35% solvent B in 60 minutes. Ions were introduced by positive 642	
electrospray ionization via liquid junction into a Q Exactive hybrid mass spectrometer (Thermo). 643	
Mass spectra were acquired over m/z 300-1750 at 70,000 resolution (m/z 200) and data-644	
dependent acquisition selected the top 10 most abundant precursor ions for tandem mass 645	
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spectrometry by HCD fragmentation using an isolation width of 1.6 Da, collision energy of 27, 646	
and a resolution of 17,500.  647	
Raw data files were peak processed with Mascot Distiller (Matrix Science, version 2.6) prior to 648	
database searching with Mascot Server (version 2.6) against the Uniprot_Human database.  Search 649	
parameters included trypsin specificity with two missed cleavages. The variable modifications of 650	
oxidized methionine, pyroglutamic acid for N-terminal glutamine, N-terminal acetylation of the 651	
protein, biotin-phenol on tyrosine and a fixed modification for carbamidomethyl cysteine were 652	
considered.  For SILAC labels, the medium samples were labeled with Lys4 and Arg6 and the 653	
heavy samples were labeled with Lys8 and Arg10.  The mass tolerances were 10 ppm for the 654	
precursor and 0.05 Da for the fragments.  SILAC ratio quantitation was accomplished using 655	
Mascot Distiller and the results from Mascot Distiller were loaded into the Scaffold Viewer 656	
(Proteome Software, Inc., version 4.8.4) for peptide/protein validation and SILAC label 657	
quantitation.  For SILAC experiments, protein identification was subject to a two-peptide cut-off. 658	
For proteins detectable in the H sample but that lack an empirical H/L ratio value (due to low 659	
background detection in the L sample), peak areas of all the identified peptides in the Distiller file 660	
were used to calculate H/L ratios.  661	
 662	
Data analysis. Data was first filtered to exclude proteins detected in only one of the dCas9-663	
mCherry-APEX2/sgTelo (+BP, +H2O2) (“S1”) replicates, followed by log2 transformation. Prior 664	
to the log2 transformation, iBAQ values of 0 were replaced with the smallest iBAQ value from 665	
the corresponding sample in dCas9-mCherry-APEX2/sgTelo (+BP, -H2O2) (“S2”) or dCas9-666	
mCherry-APEX2/sgNS (+BP, +H2O2) (“S3”) to avoid generation of infinite ratios. Moderated t-667	
test with a paired design was used to compare the log2 transformed iBAQ values between S1 and 668	
S3, S1 and S2, and S2 and S3 using limma package37. To adjust for multiple comparisons, p 669	
values were adjusted using the Benjamini-Hochberg (BH) method38. Proteins were selected for 670	
subsequent analysis if they were (i) significantly enriched in both S1 vs. S3 and S1 vs. S2, (ii) not 671	
enriched in S2 vs. S3, and (iii) if S1/S3 and S1/S2 ratios were greater than 2.  672	
Similarly, SILAC datasets were filtered to exclude proteins with H/M ratios detected in only one 673	
of the biological replicates. Detection in a biological replicate required identification in at least 674	
two of the three technical replicates that were done for each biological replicate; median values 675	
from the technical replicates were used for subsequent analyses. Proteins with BH-adjusted p 676	
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values less than 0.01 (moderated t-test described above) are considered statistically significant. 677	
Proteins (with BH-adjusted p values < 0.01 and log2 fold change ≥ 2.5) were selected for 678	
subsequent GO (David Bioinformatics) and overlap analysis. To determine whether the proteins 679	
identified in this experiment overlap significantly with three published datasets, hypergeometric 680	
test was used. Hypergeometric test was also used for testing the overlapping proteins between C-681	
BERST telomere IDs and centromere IDs. 682	
 683	
 684	
31. Follit, J.A., Tuft, R.A., Fogarty, K.E. & Pazour, G.J. The intraflagellar transport protein 685	
IFT20 is associated with the Golgi complex and is required for cilia assembly. Mol Biol Cell 17, 686	
3781-3792 (2006). 687	
32. Nagano, T. et al. Single-cell Hi-C reveals cell-to-cell variability in chromosome structure. 688	
Nature 502, 59-64 (2013). 689	
33. Zhang, Z., Theurkauf, W.E., Weng, Z. & Zamore, P.D. Strand-specific libraries for high 690	
throughput RNA sequencing (RNA-Seq) prepared without poly(A) selection. Silence 3, 9 691	
(2012). 692	
34. Kelstrup, C.D. et al. Rapid and deep proteomes by faster sequencing on a benchtop 693	
quadrupole ultra-high-field Orbitrap mass spectrometer. J Proteome Res 13, 6187-6195 (2014). 694	
35. Keller, A., Nesvizhskii, A.I., Kolker, E. & Aebersold, R. Empirical statistical model to 695	
estimate the accuracy of peptide identifications made by MS/MS and database search. Anal 696	
Chem 74, 5383-5392 (2002). 697	
36. Nesvizhskii, A.I., Keller, A., Kolker, E. & Aebersold, R. A statistical model for identifying 698	
proteins by tandem mass spectrometry. Anal Chem 75, 4646-4658 (2003). 699	
37. Smyth, G.K. Linear models and empirical Bayes methods for assessing differential expression 700	
in microarray experiments. Stat Appl Genet Molec Biol 3, 1-25 (2004).  701	
38. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful 702	
approach to multiple testing. J R Stat Soc B 57, 289-300 (1995).  703	
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Figure 1  Using C-BERST to biotinylate telomere-associated proteins in living human cells. (a) 705	
Diagram of the C-BERST workflow. U2OS cells stably expressing sgRNA and inducible 706	
dSpyCas9-APEX2 are generated by lentiviral transduction. Following dox and Shield1 induction 707	
(21 h), cells are incubated with biotin-phenol (BP, 30 min) and then H2O2 (1 min) to activate a 708	
burst of biotin-phenoxyl radical generation by dSpyCas9-APEX2, leading to proximity-labeling 709	
of nearby proteins. Following quenching, nuclei isolation and protein extraction, biotinylated 710	
proteins are enriched by streptavidin selection and analyzed by LC-MS/MS. (b) The dSpyCas9-711	
mCherry-APEX2 and sgRNA lentiviral expression constructs. Top: dSpyCas9-mCherry-APEX2 712	
under the control of the pCMV_TetO inducible promoter. The mCherry fusion is included to 713	
enable quantification of dSpyCas9 expression level as well as its subcellular localization. NLS, 714	
nuclear localization signal; LTR, long terminal repeat; DD, Shield1-repressible degradation 715	
domain. Bottom: sgRNA/TetR/BFP expression construct. pU6, U6 promoter; pPGK, PGK 716	
promoter; sgTelo, telomere-targeting sgRNA; sgNS, non-specific sgRNA; tetR, tet repressor; 717	
P2A, 2A self-cleaving peptide; BFP, blue fluorescent protein. (c) FACS sorting of untransduced 718	
(blue) and mCherry- and BFP-positive cells (red). The P1 population corresponds to high BFP (as 719	
a surrogate for sgRNA and TetR) and low mCherry expression, providing optimal signal-to-noise 720	
ratio to maximize the fraction of telomere-localized dSpyCas9-mCherry-APEX2. (d) 721	
Fluorescence imaging of dSpyCas9-mCherry-APEX2 labeling in cells. Stable sgTelo and sgNS 722	
cells were labeled live as described in (a) or were only supplemented with H2O2 as a no-labeling 723	
control. Cells were then fixed and stained with neutravidin conjugated with OG488 to visualize 724	
biotinylated proteins. dCas9-mCherry-APEX2 localization are indicated by mCherry 725	
fluorescence. Scale bar, 5 µm.   726	
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Figure 2 Successful capture of telomere-associated proteins in living human cells by C-BERST 731	
using Label Free Quantification (LFQ). (a) Top: Western blot analysis of dSpyCas9-mCherry-732	
APEX2 biotinylation, as detected by streptavidin-HRP. sgRNAs, BP treatment, and H2O2 733	
treatment are indicated at the top of each lane. Anti-mCherry was used to detect dSpyCas9-734	
mCherry-APEX2 (middle), and anti-HDAC1 was used as a loading control (bottom). (b) 735	
Coomassie-stained SDS-PAGE of total protein from isolated nuclei following biotin labeling. (c) 736	
Silver-stained SDS-PAGE of biotin-labeled proteins enriched with streptavidin-coated beads. In 737	
a-c, the mobilities of protein markers (in kDa) are indicated on the left of each panel. (d) Volcano 738	
plot of C-BERST-labeled, telomere-associated proteins in U2OS cells. Intensity-based absolute 739	
quantification (iBAQ) values from the MS analyses were calculated for each identified protein for 740	
all three samples (sgTelo + H2O2, sgTelo - H2O2, and sgNS + H2O2). 143 proteins (indicated by 741	
blue and red) are statistically enriched [Benjamini-Hochberg (BH)-adjusted p value < 0.05] in the 742	
sgTelo + H2O2 sample, relative to both control samples. The 30 proteins indicated by blue dots 743	
(with identities provided) are previously defined as either telomere-associated proteins or ALT 744	
pathway components. These include all six shelterin components. 745	
 746	
 747	
 748	
 749	
 750	
 751	
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 752	
Figure 3 Ratiometric C-BERST tagging strategy improves telomere-associated proteome 753	
identification. Volcano plot of C-BERST-labeled, telomere-associated proteins in U2OS cells. 754	
For each protein, the H/M SILAC ratio reflects the enrichment of identified proteins in sgTelo 755	
vs. sgNS cells. 359 proteins (indicated by blue and red) are statistically enriched [Benjamini-756	
Hochberg (BH)-adjusted p value < 0.05] in the sgTelo, relative to sgNS controls (indicated by red 757	
dots). 55 proteins fall within the cut-off based on FDR and enrichment level (BH-adjusted p value 758	
< 0.01 and log2 fold change ≥ 2.5). The 34 proteins indicated by blue dots (with identities 759	
provided) are previously defined as either telomere-associated proteins or ALT pathway 760	
components. The volcano plot shows 97.1% of identified proteins (inset shows all proteins, 761	
including the few with SILAC H/M log2 ratios < 0). 762	
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Figure 4 Comparison of the C-BERST telomere-associated proteome (based on the SILAC 764	
dataset) with other approaches, and validation of novel telomeric factors. (a) Gene Ontology-765	
Biological Process (GO-BP) analysis on the 55 telomeric/ALT proteins identified by C-BERST. 766	
The x-axis is the -log10 p value (BH-adjusted) for the C-BERST-detected proteins associated with 767	
each GO term given on the left. The 20 most statistically significant GO terms are displayed. (b) 768	
Venn diagram of statistically enriched (BH-adjusted p value < 0.01) telomeric proteins from ALT 769	
human cells, as detected by C-BERST (red), PICh (purple), and TRF1-BirA* BioID (green). 32 770	
proteins from the C-BERST proteome were also detected by PICh, BioID, or both. (c) A heat 771	
map of the C-BERST log2 fold-change enrichment scores for the 18 telomeric proteins identified 772	
by all three proteomic approaches from (b). All 18 proteins are highly enriched in the C-BERST 773	
telomere proteome. The one underlined protein (SLX4IP) has not been reported previously (to 774	
our knowledge) as telomere- or ALT-associated. (d) Colocalization of turboGFP-tagged SLX4IP 775	
and RPA3 with telomeric marker protein TRF2. 0.3 x 105 U2OS cells were transiently 776	
transfected with 100ng SLX4IP-GFP expression plasmid or 50ng RPA3-GFP expression plasmid. 777	
Cells were then fixed and incubated with TRF2 primary antibody and secondary antibody 778	
conjugated with Alexa Fluor 647. DAPI stained cells were imaged (n ≥ 20 cells examined). Scale 779	
bar, 5 µm.  780	
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 781	
Figure 5 Successful capture of alpha satellite associated proteomes in live human cells by C-782	
BERST. (a) Schematic diagram of alpha satellite repeat position and arrangement at a 783	
centromere. (b) Live-cell imaging of centromere localization by dSpyCas9-mCherry-APEX2 in 784	
U2OS cells, using the P1-sorted population defined by the FACS workflow in Fig. 1c. 785	
dSpyCas9-mCherry-APEX2 exhibited centromeric foci with sgAlpha but not with sgNS. Scale 786	
bar, 5 µm. (c) Ratiometric C-BERST (using SILAC) was used to profile the alpha satellite 787	
associated proteome.  A volcano plot of C-BERST-labeled, centromere-associated proteins in 788	
U2OS cells is shown. For each protein, the H/M SILAC ratio reflects the enrichment of 789	
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identified proteins in sgAlpha vs. sgNS cells. 1134 proteins (indicated by blue and red dots) are 790	
statistically enriched [Benjamini-Hochberg (BH)-adjusted p value < 0.05] in the sgAlpha sample, 791	
relative to sgNS controls. 460 proteins fall within the cut-off based on FDR and enrichment level 792	
(BH-adjusted p value < 0.01 and log2 fold change ≥ 2.5). The 40 proteins indicated by blue dots 793	
(with identities provided) were previously defined as either centromere-associated proteins 794	
(Supplementary Table 5) or were reported as components of the HyCCAPP centromere 795	
proteome (see text). The nine known centromere-associated proteins indicated by red lines are 796	
uniquely captured by C-BERST. The volcano plot shows 96.2% of identified proteins (inset 797	
shows all proteins, including the few with SILAC H/M ratio < 0 and -log10 adjusted p value < 1).  798	
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 799	
Supplementary Fig. 1 Inducible dSpyCas9-mCherry-APEX2 expression. (a) Flow cytometry 800	
was used to measure the percentage of mCherry+ and BFP+ double-positive cells under different 801	
induction conditions. Stable U2OS cells expressing sgTelo (top row) or sgNS (bottom row) were 802	
exposed to three conditions for 21h before flow cytometry: no inducers (left), dox only (2 µg/ml, 803	
middle), or a combination of dox (2 µg/ml) and Shield1 (250 nM) (right). Cyan: untransduced 804	
cells; red: transduced cells. With both sgRNAs, dox and Shield1 in combination yield the highest 805	
percentages of double-positive cells. Specific percentages of mCherry+, BFP+ cells are indicated 806	
in each plot. (b) Live-cell imaging of clonal cells derived from the sgTelo P1 population (see Fig. 807	
1c). When inducers are omitted, dSpyCas9-mCherry-APEX2 expression and telomeric  808	
accumulation are not observed. Scale bar, 5 µm. 809	
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 810	
Supplementary Fig. 2 Specific telomere targeting by dSpyCas9-mCherry-APEX2. (a) Live-811	
cell imaging of telomere localization by dSpyCas9-mCherry-APEX2 in U2OS cells, using the 812	
P1-sorted population defined by the FACS workflow in Fig. 1c. dSpyCas9-mCherry-APEX2 813	
exhibited telomeric foci with sgTelo but not with sgNS. (b) Immunostaining of telomeric marker 814	
protein with primary anti-TERF2IP and secondary antibody conjugated with Alexa 488. 815	
Colocalization of dSpyCas9-mCherry-APEX2 foci with TERF2IP is observed (n ≥ 25 cells 816	
examined). Scale bar, 5 µm. 817	
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 818	
Supplementary Fig. 3 anti-mCherry chromatin immunoprecipitation shows genome-wide 819	
binding of sgTelo-programmed dSpyCas9-mCherry-APEX2. The reads were trimmed by 820	
adaptor removal and filtering. The percentage of total trimmed reads that include at least one 821	
(TTAGGG)4 telomeric sequence (the minimum length required for complete sgTelo 822	
complementarity) is shown. Values were averaged from two independent biological replicates, 823	
except for the U2OS ChIP-seq, which was only performed once.  824	
sg
Te
lo
sg
NS
U2
OS
0.0
0.2
0.4
0.6
0.8
1.0
Pe
rc
en
ta
ge
 o
f t
ot
al
 tr
im
m
ed
 re
ad
s 
co
nt
ai
ni
ng
 (T
TA
G
G
G
) 4
ChIP-seq
0.575
0.004 0.002
.CC-BY 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/171819doi: bioRxiv preprint first posted online Aug. 2, 2017; 
 37 
 825	
Supplementary Fig. 4 (a) Schematic diagram of SILAC workflow. Cells were grown in 826	
different isotope culture media for at least five passages. dSpyCas9-mCherry-APEX2 proteins 827	
were induced by dox and Shield1 21 hours before biotinylation. Following biotinylation and 828	
nuclei isolation, cell lysates were sonicated and mixed in a 1:1:1 ratio. (b) Anti-mCherry was used 829	
to detect dSpyCas9-mCherry-APEX2 (top), and anti-HDAC1 was used as a loading control 830	
(bottom) in the western blot analysis. 831	
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 832	
Supplementary Fig. 5  C-BERST specifically detects components of multiple complexes and 833	
factors implicated in ALT pathways. Proteins denoted by double asterisks were significantly 834	
enriched (p value < 0.01) and meet the SILAC cut-off log2 fold change ≥ 2.5 in the sgTelo 835	
labeling sample, relative to the sgNS labeling samples (H/M) ratio (see Supplementary Table 836	
3). Proteins denoted by single asterisks were also detected but with lower degrees of significance 837	
(BH-adjusted p value < 0.05) in the sgTelo labeling sample (Supplementary Table 3). Proteins 838	
denoted by a hashtag were enriched and statistically significant in LFQ. Components of the 839	
RAD9/RAD1/HUS1 complex (see Supplementary Table 3) were not detected.  840	
 841	
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 843	
 844	
 845	
MRN complex Break-induced telomere synthesisShelterin complex
SMC5/6/MMS21 complexCTC1/STN1/TEN1 complex
TRF1** TRF2**
TIN2**
TPP1**
POT1**
RAP1**
CTC1**
TEN1
STN1**
NBN**
Rad50**
PCNA
POLD3#
RFC*
SMC5**
MMS21
SMC6*
ERCC1-XPF complex
ERCC1** XPF**
MRE11**
.CC-BY 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/171819doi: bioRxiv preprint first posted online Aug. 2, 2017; 
 39 
 846	
Supplementary Fig. 6 Western blot analysis of exogenous, turboGFP-tagged SLX4IP or 847	
RPA3 expression, in comparison with the corresponding endogenous protein. ~0.1 x 105 U2OS 848	
cells transfected with SLX4IP-turboGFP or RPA3-turboGFP expression plasmid (100 ng and 50 849	
ng, respectively) were lysed in 1x RIPA lysis buffer, and proteins were resolved by SDS-PAGE. 850	
Western blots were probed by primary SLX4IP or RPA3 antibody and anti-rabbit secondary 851	
antibody conjugated with HRP. The gel lanes shown in each panel were cropped from identical 852	
exposures of the same western blot membranes. 853	
 854	
 855	
 856	
Supplementary Fig. 7 Coimmunostaining of TRF2 (telomeric marker protein) and SLX4IP 857	
protein. Primary goat anti-TRF2 and rabbit anti-SLX4IP were used to detect endogenous TRF2 858	
and SLX4IP in the fixed U2OS cells. Secondary donkey anti-goat conjugated with Alexa 647 859	
and mouse anti-rabbit conjugated with CruzFluorTM 488 were then incubated with cells. Scale 860	
bar, 5 µm. 861	
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 865	
 866	
 867	
 868	
 869	
 870	
 871	
Supplementary Fig. 8 (a) Western blot analysis of dSpyCas9-mCherry-APEX2 expression 872	
using anti-mCherry to detect dSpyCas9-mCherry-APEX2 (top). Anti-HDAC1 was used as a 873	
loading control (bottom). (b) Streptavidin-HRP blotting analysis of biotinylated proteins in 874	
sgAlpha- and sgNS-expressing cells. Untransduced U2OS cells were used as a control. 875	
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 876	
Supplementary Fig. 9 (a) Venn diagram of statistically enriched (BH-adjusted p value < 0.01) 877	
460 centromeric proteins from U2OS cells, as detected by C-BERST (red), and 90 centromeric 878	
proteins from K562 cells, as detected by HyCCAPP (cyan) (see text). 31 proteins from the C-879	
BERST proteome were detected by both. (b) Gene Ontology-Biological Process (GO-BP) 880	
analysis on 460 centromeric proteins identified by C-BERST. The x-axis is the -log10 p value 881	
(BH-adjusted) for the C-BERST-detected proteins associated with each GO term given on the 882	
left. The 15 most statistically significant GO terms are displayed.  883	
 884	
 885	
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 886	
Supplementary Fig. 10 Venn diagram of 55 C-BERST ALT/telomeric IDs and 460 887	
centromeric IDs. 19 non-overlapping telomere IDs are listed on the right. Known 888	
ALT/telomeric proteins are underlined. Among the 424 non-overlapping centromere IDs, 33 889	
(listed on the left) are known or implicated as centromeric proteins. 36 overlapping proteins from 890	
both sets are listed below the Venn diagram, as indicated. The five most significant GO-BP terms 891	
for the 36 overlapping ID are provided on the lower right.  892	
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Supplementary Note dSpyCas9-mCherry-APEX2, sgTelo, and sgNS sequences. 
 
 
Amino acid sequence of dSpyCas9-mCherry-APEX2 
 
Legend: NLS DD dSpyCas9 mCherry FLAG APEX2  
 
MAPKKKRKVEDKRPAATKKAGQAKKKKEDACGVQVETISPGDGRTFPKRGQTCVVHYTGMLE
DGKKVDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPH
ATLVFDVELLKPEGSEFGSGSDKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKK
NLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEED
KKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNP
DNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLI
ALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRV
NTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFY
KFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREK
IEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPN
EKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDY
FKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERL
KTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDD
SLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMAR
ENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQEL
DINRLSDYDVDAIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLI
TQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVIT
LKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKM
IAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVL
SMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEK
GKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASA
GELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVIL
ADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLI
HQSITGLYETRIDLSQLGGDGSTSGSPKKKRKVGSGSMVSKGEEDNMAIIKEFMRFKVHMEGS
VNGHEFEIEGEGEGRPYEGTQTAKLKVTKGGPLPFAWDILSPQFMYGSKAYVKHPADIPDYLK
LSFPEGFKWERVMNFEDGGVVTVTQDSSLQDGEFIYKVKLRGTNFPSDGPVMQKKTMGWEA
SSERMYPEDGALKGEIKQRLKLKDGGHYDAEVKTTYKAKKPVQLPGAYNVNIKLDITSHNEDYT
IVEQYERAEGRHSTGGMDELYKSGGRGGGGSDYKDDDDKGKSYPTVSADYQDAVEKAKKKL
RGFIAEKRCAPLMLRLAFHSAGTFDKGTKTGGPFGTIKHPAELAHSANNGLDIAVRLLEPLKAEF
PILSYADFYQLAGVVAVEVTGGPKVPFHPGREDKPEPPPEGRLPDPTKGSDHLRDVFGKAMGL
TDQDIVALSGGHTIGAAHKERSGFEGPWTSNPLIFDNSYFTELLSGEKEGLLQLPSDKALLSDP
VFRPLVDKYAADEDAFFADYAEAHQKLSELGFADALEPKKKRKVEDKRPAATKKAGQAKKKKG
S* 
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Nucleotide sequence of sgRNA/TetR_P2P_BFP 
 
Legend: U6 promoter Guide sequence sgRNA scaffold hPGK promoter TetR P2A BFP NLS 
 
ccccttcaccgagggcctatttcccatgattccttcatatttgcatatacgatacaaggctgttagagagataattggaattaatttgactgta
aacacaaagatattagtacaaaatacgtgacgtagaaagtaataatttcttgggtagtttgcagttttaaaattatgttttaaaatggactat
catatgcttaccgtaacttgaaagtatttcgatttcttggctttatatatcttgtggaaaggacgaaacaccgNNNNNNNNNNNNN
NNNNNNNtttaagagctatgctggaaacagcatagcaagtttaaataaggctagtccgttatcaacttgaaaaagtggcaccgag
tcggtgctttttttgaattctcgacctcgagacaaatggcagtattcatccacaattttaaaagaaaaggggggattggggggtacagtgc
aggggaaagaatagtagacataatagcaacagacatacaaactaaagaattacaaaaacaaattacaaaaattcaaaattttcgg
gtttattacagggacagcagagatccactttggccgcggctcgagggggttggggttgcgccttttccaaggcagccctgggtttgcgc
agggacgcggctgctctgggcgtggttccgggaaacgcagcggcgccgaccctgggtctcgcacattcttcacgtccgttcgcagcg
tcacccggatcttcgccgctacccttgtgggccccccggcgacgcttcctgctccgcccctaagtcgggaaggttccttgcggttcgcgg
cgtgccggacgtgacaaacggaagccgcacgtctcactagtaccctcgcagacggacagcgccagggagcaatggcagcgcgc
cgaccgcgatgggctgtggccaatagcggctgctcagcagggcgcgccgagagcagcggccgggaaggggcggtgcgggagg
cggggtgtggggcggtagtgtgggccctgttcctgcccgcgcggtgttccgcattctgcaagcctccggagcgcacgtcggcagtcgg
ctccctcgttgaccgaatcaccgacctctctccccagggggatccgtgagtttggggacccttgattgttctttctttttcgctattgtaaaatt
catgttatatggagggggcaaagttttcagggtgttgtttagaatgggaagatgtcccttgtatcaccatggaccctcatgataattttgtttc
tttcactttctactctgttgacaaccattgtctcctcttattttcttttcattttctgtaactttttcgttaaactttagcttgcatttgtaacgaatttttaaa
ttcacttttgtttatttgtcagattgtaagtactttctctaatcacttttttttcaaggcaatcagggtatattatattgtacttcagcacagttttagag
aacaattgttataattaaatgataaggtagaatatttctgcatataaattctggctggcgtggaaatattcttattggtagaaacaactacat
cctggtcatcatcctgcctttctctttatggttacaatgatatacactgtttgagatgaggataaaatactctgagtccaaaccgggcccctc
tgctaaccatgttcatgccttcttctttttcctacagctcctgggcaacgtgctggttattgtgctgtctcatcattttggcaaagaattgtaatac
gactcactatagggcgaattgatatgtctagattagataaaagtaaagtgattaacagcgcattagagctgcttaatgaggtcggaatc
gaaggtttaacaacccgtaaactcgcccagaagctaggtgtagagcagcctacattgtattggcatgtaaaaaataagcgggctttgc
tcgacgccttagccattgagatgttagataggcaccatactcacttttgccctttagaaggggaaagctggcaagattttttacgtaataa
cgctaaaagttttagatgtgctttactaagtcatcgcgatggagcaaaagtacatttaggtacacggcctacagaaaaacagtatgaaa
ctctcgaaaatcaattagcctttttatgccaacaaggtttttcactagagaatgcattatatgcactcagcgctgtggggcattttactttagg
ttgcgtattggaagatcaagagcatcaagtcgctaaagaagaaagggaaacacctactactgatagtatgccgccattattacgaca
agctatcgaattatttgatcaccaaggtgcagagccagccttcttattcggccttgaattgatcatatgcggattagaaaaacaacttaaa
tgtgaaagtgggtccgcgtacagcggctcccgggagttcgctagcggtgctactaacttcagcctgctgaagcaggctggagacgtg
gaggagaaccctggacctggtagtggaacgcgtatggtgtctaagggcgaagagctgattaaggagaacatgcacatgaagctgt
acatggagggcaccgtggacaaccatcacttcaagtgcacatccgagggcgaaggcaagccctacgagggcacccagaccatg
agaatcaaggtggtcgagggcggccctctccccttcgccttcgacatcctggctactagcttcctctacggcagcaagaccttcatcaa
ccacacccagggcatccccgacttcttcaagcagtccttccctgagggcttcacatgggagagagtcaccacatacgaagatgggg
gcgtgctgaccgctacccaggacaccagcctccaggacggctgcctcatctacaacgtcaagatcagaggggtgaacttcacatcc
aacggccctgtgatgcagaagaaaacactcggctgggaggccttcaccgagacgctgtaccccgctgacggcggcctggaaggc
agaaacgacatggccctgaagctcgtgggcgggagccatctgatcgcaaacgccaagaccacatatagatccaagaaacccgct
aagaacctcaagatgcctggcatctactatgtggactacagactggaaagaatcaaggaggccaacaacgaaacctacgtcgagc
agcacgaggtggcagtggccagatactgcgacctccctagcaaactggggcacaagcttaatccaaagaaaaagcggaaagtg 
 
Guide sequences: 
sgTelo: gTTAGGGTTAGGGTTAGGGTT 
sgNS: gAATCTCGCTTATATAACGAG 
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